Lobbying Information
Subject Matters
Subject matters added through a monthly communication report
Subject Matter Details
Legislative Proposal, Bill or Resolution, Regulation
- Bill C-45, the Cannabis Act and Cannabis Regulations, with respect to the licensing, regulation, production, promotion, distribution, export and sale of cannabis and cannabis products.
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Finance Canada (FIN)
-
Health Canada (HC)
Government institutions added through a monthly communication report
- House of Commons
- Innovation, Science and Economic Development Canada (ISED)
In-house Corporation Details
Description of activities
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®.
Responsible officer name and position during the period of this registration
Michael Gorenstein,
President & CEO
Government funding
No government funding was received during the last completed financial year.
In-house Corporation Contact Information
Address:
111 Peter Street, Suite 300
Toronto, ON M5V 2H1
Canada
Telephone number:
416-504-0004
Parent Company Information
Cronos Group Inc. is not a subsidiary of any other parent companies.
Subsidiary Beneficiary Information
- Original BC Ltd.
-
111 Peter Street, Suite 300
Toronto, ON M5V 2H1
Canada
- Peace Naturals Project Inc.
-
111 Peter Street, Suite 300
Toronto, ON M5V 2H1
Canada
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Michael Gorenstein,
President & CEO |
No public offices held
- Jeffrey Jacobson,
SVP, Head of Growth |
No public offices held
- Pete Meachum,
VP, Government Affairs |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
No lobbyists added